Yuki Noguchi
Stories
-
What does a 'GLP-1 Friendly' diet look like? We asked nutritionists
Big food companies are starting to market to people on the powerful new obesity meds with labels that say "GLP-1 Friendly." Nutritionists help us decode that message.
-
Ivermectin is making a post-pandemic comeback, among cancer patients
The anti-parasitic drug became a household name during the COVID-19 pandemic, and it is now being embraced as an alternative treatment for cancer. It is as politically polarizing as ever.
-
Using saliva to detect disease holds promise, but it's not perfected yet
Easier than a blood test, saliva tests have the potential to detect cavities, infections and even cancer. But a lack of insurance coverage and other obstacles stand in the way of wider use.
-
Using GLP-1s to maintain a normal weight? There are benefits and risks
Drugs like Zepbound and Wegovy are intended for people who are overweight. Some patients are using them after bariatric surgery to keep pounds from creeping back. Others may just want to lose a few pounds.
-
GLP-1 obesity drugs can complicate life for people with disordered eating
Doctors, patients and researchers are at the very beginning of understanding how the new weight loss medicines interact with eating disorders.
-
As GLP-1s become more available, some who aren't overweight may consider using them
As GLP-1 drugs become more available, some people might use them despite not having excess weight.
-
GLP-1s don't always work for weight loss. Researchers are trying to figure out why
GLP-1 weight loss drugs have transformed obesity treatment, but not everyone loses lots of weight. Researchers say figuring out why is the key to the future of this treatment method.
-
White House announces new round of drug-price deals
Fourteen companies in total have now reached what the administration calls most-favored-nation pricing deals.
-
'Nobody wants to come': What if the U.S. can no longer attract immigrant physicians?
Immigrants make up a significant proportion of all the country's doctors. New policies are making it harder and less appealing for foreign-born physicians to come to the U.S.
-
New policies make U.S. less appealing to foreign-born physicians
Immigrants make up about a quarter of all the country's doctors. New policies are making it harder and less appealing for foreign-born physicians to come to the U.S.
